
PG Capital
60 posts

PG Capital
@_PGCapital
Investing Journal, Global Stocks, No Financial Advice


$ROST valuation: Using the high end of FY26 EPS guidance, the stock at ~$235 trades at roughly 30.4x FY26 EPS. Great quarter, great business — but at this multiple, I don’t see much IRR from here. Let’s see!

Ross Stores Q1 FY26: A monster quarter! $ROST Ross Stores delivered one of the strongest quarters in its history. Sales grew 21% YoY (17% comps, 3.5% store growth)to $6.0bn, operating margin expanded 120 bps to 13.4%, and EPS grew 37% YoY to $2.02. This was miles ahead of management’s original EPS guidance of $1.60–$1.67. The company also raised FY26 guidance to 6–7% comp growth and $7.50–$7.74 EPS, implying 13–17% EPS growth for the year. 17% comp was driven by transactions (customer count went up) aided by tax refunds. Management repeatedly talked about better connecting merchandising, marketing, and stores. Every major merchandise category posted comps in the teens or higher. Ladies and cosmetics were the strongest businesses, but the strength was broad across merchandise and geographies. dd’s DISCOUNTS also delivered solid top-line performance. Management said closeout availability remains outstanding, but the more interesting comment was that the market is noticing Ross’ growth rate. When vendors have good closeout opportunities, Ross is increasingly getting calls because it can take the goods, move volume, and act as a low-friction partner. COGS improved by 145 bps, helped by 85 bps of merchandise margin improvement, 60 bps of occupancy leverage, 15 bps of distribution leverage, and 10 bps of domestic freight leverage. This was partly offset by 25 bps of higher buying costs and 25 bps of SG&A deleverage, both due to higher incentives after the earnings outperformance. For Q2, Ross guided to 6–7% comparable sales growth, 9–11% total sales growth, 12.8–13.0% operating margin, and $1.85–$1.93 EPS. For FY26, guidance was raised to 6–7% comp growth and $7.50–$7.74 EPS.



Seems your problem is guidance from $DECK. The investment community is well aware of how this always ends up. Don't understand why you think margins should get even better - there is no case study for that. Most of us just want the algo to stay 20%+ EBIT and revenue to stay DD and the stock is a massive homerun.









Constellation Software (CSU) Q1’26 deep dive 👇 $CSU $CSU.TO IMPORTANT FRAMING (because CSU consolidates TOI + LMN) CSU consolidates 100% of both Topicus and Lumine (control via super voting). So CSU’s reported revenue / opex / cash / M&A includes TOI + LMN fully, and economics are then split via NCI (and FCFA2S deducts NCI). 1) Growth: strong headline; “maintenance organic” is the clean signal Revenue grew +20% YoY to $3,181m. Organic growth was +6% (or +2% FX-adjusted). Cleanest read is maintenance & other recurring: Maintenance +22% YoY and +9% organic (FX-adjusted +4%). Licenses were -9% organic and hardware slightly negative organically, so don’t over-read those. 2) M&A: remember LMN + TOI are inside CSU’s numbers Total consideration for acquisitions in Q1 was $809m (cash at close $697m): - Synchronoss (inside Lumine): total consideration $309m (contributed $22m revenue and ~$(2)m net loss in the partial quarter) - “Additional acquisitions”: total consideration $500m = cash $388m + holdbacks $91m + contingent $21m Cash flow bridge (to reconcile optics): Cash paid at close was $697m, and then there was another ~$69m of post-acq settlement / holdback payments → “cash used in acquisitions” shows up as $766m. CSU also acquired $77m of cash with the businesses. Standalone CSU deployment (“ex TOI + LMN” lens): Topicus did €22.5m of total consideration in Q1 (~$25–26m), so standalone CSU consideration is roughly: $809m – $309m – ~$26m ≈ ~$473m in Q1’26 (similar to Q4’25). TTM standalone consideration is ~ ~$1.5b → CSU is still chugging along on acquisitions. Bonus: post-quarter pipeline Subsequent to Mar 31, CSU completed / committed to $786m of acquisitions (cash $627m + deferred $159m). 3) Operating leverage: roughly steady (Q1 staff is seasonally optically heavy) Expenses grew +21% vs revenue +20% (expense ratio 75% → 76%). Staff grew +19% YoY. CSU reminds Q1 staff % is seasonally higher due to payroll taxes tied to annual bonus payments in March. Lumine had acquisition-related costs this quarter (not quantified at CSU level), so some staff-line noise is possible. 4) Below EBIT: lots of noise (don’t anchor on EPS without context) - FX swung hard: +$45m gain vs -$32m loss last year. - IRGA liability revaluation swung from a +$94m charge last year to a -$76m gain this year (non-cash). Important nuance: the IRGA liability fell mainly because Topicus’ listed stakes (Asseco + Sygnity) were lower, offset by Topicus’ trailing maintenance/recurring growth + net profits. - Asseco now shows up via equity-method income (~$10–11m this quarter, lagged). - Finance costs were higher due to higher average debt outstanding. 5) Cash: CFO +9%; my FCFAA math My FCFAA variant: start from CFO, subtract interest/leases/capex, add acquired cash, deduct post-acq settlement cash. In Q1’26: CFO 897 less interest / leases / capex: 111 + cash obtained from businesses: 77 – post-acq settlement payments: 69 FCFAA: ~795m in Q1 (up ~11% YoY) On TTM basis (my calc): OCF: 2,807m less interest / leases / capex: 377m FCF: 2,430m + cash obtained from businesses: 239m – post-acq settlement payments: 339m FCFAA: ~2,330m TTM (Note: this includes 100% of Topicus + Lumine, so be careful with valuation.) 6) Balance sheet / dry powder Cash ~$3.01bn and total debt ~$3.99bn → net debt ~$0.98bn (ex leases). Lease obligations are ~0.44bn → “incl leases” net debt ~1.44bn (~0.4x net debt / TTM EBITDA). CSI Facility is $1.085bn and was undrawn at quarter-end (only ~$13m letters of credit). Net-net: good organic (especially maintenance), steady M&A machine, and strong Q1 cash generation.











